EnPlusOne Biosciences
Homepage - EnPlusOne Bio
Watertown, United States · $22.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- enplusone.bio
- Total Funding
- $22.0M
- Last Round
- $10.0M SeedFeb 2025
- Rounds
- 2
About
RNA therapeutics biotech using enzymatic synthesis to produce higher-quality RNA oligonucleotides.
Summary
EnPlusOne Biosciences is a Biotech company based in Watertown, United States. It has raised $22.0M in total across 2 rounds, most recently a $10.0M Seed round in Feb 2025. Investors include Northpond Ventures and Breakout Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.